Upgrade to SI Premium - Free Trial

Macrogenics (MGNX)

4.40 +0.15 (3.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/4/26)

Latest Headlines

Form 4 MACROGENICS INC For: Aug 19 Filed by: Peters Jeffrey Stuart August 20, 2026 6:19 PM - SEC Filing Form 144 MACROGENICS INC Filed by: Peters Jeffrey Stuart August 19, 2026 5:20 PM - SEC Filing Form 4 MACROGENICS INC For: Aug 17 Filed by: Bonvini Ezio August 18, 2026 4:19 PM - SEC Filing Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP August 17, 2026 5:37 PM - SEC Filing MacroGenics (MGNX) PT Raised to $11 at B.Riley August 17, 2026 9:09 AM - StreetInsider Form 10-Q MACROGENICS INC For: Jun 30 August 14, 2026 4:27 PM - SEC Filing Form SCHEDULE 13G/A MACROGENICS INC Filed by: ARMISTICE CAPITAL, LLC August 14, 2026 10:22 AM - SEC Filing Macrogenics (MGNX) Misses Q2 EPS by 102c August 13, 2026 4:23 PM - StreetInsider Form 8-K MACROGENICS INC For: Aug 13 August 13, 2026 4:10 PM - SEC Filing MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position August 13, 2026 4:06 PM - Globe NewsWire Gilead exercises option on MacroGenics bispecific program, triggering $10M August 11, 2026 4:05 PM - StreetInsider MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program August 11, 2026 4:05 PM - StreetInsider Form 144 MACROGENICS INC Filed by: SIEGEL JAY PHILIP August 3, 2026 4:31 PM - SEC Filing Form SCHEDULE 13G/A MACROGENICS INC Filed by: BANK OF AMERICA CORP /DE/ August 3, 2026 4:18 PM - SEC Filing Form SCHEDULE 13G MACROGENICS INC Filed by: BlackRock, Inc. July 29, 2026 3:21 PM - SEC Filing MacroGenics (MGNX) Reiterated at Market Perform by Citizens Ahead of ESMO '26 Data July 27, 2026 5:24 AM - StreetInsider Form 8-K MACROGENICS INC For: Jul 23 July 23, 2026 4:07 PM - SEC Filing MacroGenics reports Phase 1 progress for MGC026 ahead of ESMO 2026 July 23, 2026 4:01 PM - StreetInsider MacroGenics MGC026 trial advances to stage 2 in head and neck cancer July 23, 2026 4:01 PM - StreetInsider MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 July 23, 2026 4:01 PM - Globe NewsWire MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026 July 23, 2026 4:01 PM - StreetInsider Leerink Assumes MacroGenics (MGNX) at Outperform July 21, 2026 4:49 PM - StreetInsider Form SCHEDULE 13G/A MACROGENICS INC Filed by: MILLENNIUM MANAGEMENT LLC July 20, 2026 5:25 PM - SEC Filing Form 144 MACROGENICS INC Filed by: Spitznagel Thomas July 13, 2026 9:26 PM - SEC Filing Karen Ferrante to resign from MacroGenics board in September July 8, 2026 4:02 PM - StreetInsider Form 8-K MACROGENICS INC For: Jul 01 July 8, 2026 4:01 PM - SEC Filing MacroGenics sells CDMO operations to Bora Pharmaceuticals for $122.5M July 7, 2026 4:34 PM - StreetInsider Form 8-K MACROGENICS INC For: Jun 30 July 7, 2026 4:30 PM - SEC Filing MacroGenics sells GMP manufacturing unit to Bora for $122.5M July 2, 2026 9:25 AM - StreetInsider MacroGenics sells GMP manufacturing unit to Bora for $122.5M July 2, 2026 9:25 AM - StreetInsider MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals July 2, 2026 9:25 AM - Globe NewsWire MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals July 2, 2026 9:25 AM - StreetInsider MacroGenics to receive $24.5M milestone from Sanofi on FDA approval June 22, 2026 4:44 PM - StreetInsider MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval June 22, 2026 4:43 PM - Globe NewsWire Full Article List